Snowball logo
logo
INTS

Intensity Therapeutics Inc.

INTS โ€ข NASDAQ
$5.25+$0.04ย  (0.77%)

Frequently asked questions

What sector does Intensity Therapeutics Inc. (INTS) operate in?

Intensity Therapeutics Inc. belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Intensity Therapeutics Inc. (INTS) current stock price?

As of the latest data, Intensity Therapeutics Inc. stock price is $5.25, with a previous close of $5.21. Intensity Therapeutics Inc. gained $0.04 in the last trading session, representing a 0.77% increase.

What is Intensity Therapeutics Inc. (INTS) current market capitalization?

Intensity Therapeutics Inc. market cap is approximately 13.34 million.

What is Intensity Therapeutics Inc. (INTS) Earnings Per Share (EPS)?

The trailing EPS is -$8.56, and the forward EPS is -$2.95.

What is Intensity Therapeutics Inc. (INTS) EBITDA?

Intensity Therapeutics Inc. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -3.13 million.

Does Intensity Therapeutics Inc. (INTS) pay dividends?

No. Intensity Therapeutics Inc. does not pay a dividend.

When is Intensity Therapeutics Inc. (INTS) next earnings report?

Intensity Therapeutics Inc. is expected to release its next earnings report on March 31, 2026.

What is Intensity Therapeutics Inc. (INTS) beta (volatility) score?

Intensity Therapeutics Inc. has a beta of 4.232, indicating very high volatility compared to the market.